JP2010513459A - セコタキサンの調製方法 - Google Patents

セコタキサンの調製方法 Download PDF

Info

Publication number
JP2010513459A
JP2010513459A JP2009542257A JP2009542257A JP2010513459A JP 2010513459 A JP2010513459 A JP 2010513459A JP 2009542257 A JP2009542257 A JP 2009542257A JP 2009542257 A JP2009542257 A JP 2009542257A JP 2010513459 A JP2010513459 A JP 2010513459A
Authority
JP
Japan
Prior art keywords
formula
removal
branched
linear
oxazolidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009542257A
Other languages
English (en)
Japanese (ja)
Inventor
ガブリエラ フォンタナ、
エツィオ ボンバルデッリ、
ブルーノ ガベッタ、
ジョヴァンニ アペンディノ、
フランチェスコ マイニエリ、
Original Assignee
インデナ エッセ ピ ア
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by インデナ エッセ ピ ア filed Critical インデナ エッセ ピ ア
Publication of JP2010513459A publication Critical patent/JP2010513459A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D305/04—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D305/08—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Epoxy Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP2009542257A 2006-12-21 2007-12-17 セコタキサンの調製方法 Pending JP2010513459A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT002479A ITMI20062479A1 (it) 2006-12-21 2006-12-21 Processo per la preparazione di secotassani
PCT/IB2007/003951 WO2008081247A2 (en) 2006-12-21 2007-12-17 A process for the preparation of secotaxanes

Publications (1)

Publication Number Publication Date
JP2010513459A true JP2010513459A (ja) 2010-04-30

Family

ID=39589051

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009542257A Pending JP2010513459A (ja) 2006-12-21 2007-12-17 セコタキサンの調製方法

Country Status (11)

Country Link
EP (1) EP2091931A2 (ko)
JP (1) JP2010513459A (ko)
KR (1) KR20090092285A (ko)
CN (1) CN101631782A (ko)
AU (1) AU2007341070A1 (ko)
CA (1) CA2673238A1 (ko)
IT (1) ITMI20062479A1 (ko)
MX (1) MX2009006581A (ko)
NO (1) NO20092337L (ko)
RU (1) RU2009123160A (ko)
WO (1) WO2008081247A2 (ko)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2696458B1 (fr) * 1992-10-05 1994-11-10 Rhone Poulenc Rorer Sa Procédé de préparation de dérivés du taxane.
DE69433146T2 (de) * 1993-06-11 2004-06-09 Pharmacia & Upjohn Co., Kalamazoo Delta 6,7-Taxol Derivate antineoplastische Verbindungen und diese enthaltende pharmazeutische Zusammenstellungen
WO1996003394A1 (en) * 1994-07-26 1996-02-08 Indena S.P.A. Semi-synthetic taxanes with anti-tumoural activity
IT1308636B1 (it) * 1999-03-02 2002-01-09 Indena Spa Procedimento per la preparazione di tassani da 10-desacetilbaccatinaiii.
ITMI991483A1 (it) * 1999-07-06 2001-01-06 Indena Spa Derivati tassanici e procedimenti per la loro preparazione
US7247738B2 (en) * 2002-05-07 2007-07-24 Dabur India Limited Method of preparation of anticancer taxanes using 3-[(substituted-2-trialkylsilyl) ethoxycarbonyl]-5-oxazolidine carboxylic acids
US6900342B2 (en) * 2002-05-10 2005-05-31 Dabur India Limited Anticancer taxanes such as paclitaxel, docetaxel and their structural analogs, and a method for the preparation thereof

Also Published As

Publication number Publication date
NO20092337L (no) 2009-07-14
AU2007341070A1 (en) 2008-07-10
WO2008081247A3 (en) 2008-10-09
EP2091931A2 (en) 2009-08-26
WO2008081247A2 (en) 2008-07-10
RU2009123160A (ru) 2010-12-27
KR20090092285A (ko) 2009-08-31
CA2673238A1 (en) 2008-07-10
MX2009006581A (es) 2009-06-30
ITMI20062479A1 (it) 2008-06-22
CN101631782A (zh) 2010-01-20

Similar Documents

Publication Publication Date Title
JP3410518B2 (ja) デオキシパクリタキセル類
US20190142784A1 (en) 9,10-Alpha,Alpha-OH-Taxane Analogs and Methods for Production Thereof
JP4144919B2 (ja) バッカチンｉｉｉおよびその誘導体類の１０−デアセチルバッカチンｉｉｉからの製造方法
JP5960130B2 (ja) テセタキセルおよび関連化合物ならびに対応する合成中間体の調製
KR100921036B1 (ko) 탁산유도체의 제조방법 및 이에 사용되는 중간체
JP2010513459A (ja) セコタキサンの調製方法
US7078432B2 (en) Process for the preparation of the 14β-hydroxy-baccatin III-1,14-carbonate
JP5154546B2 (ja) タキサン誘導体の調製法
NO332367B1 (no) Taksanderivater funksjonalisert pa den 14. posisjonen
AU2002328918A1 (en) A process for the preparation of the 14beta-hydroxy-baccatin III-1, 14-carbonate
US9284327B2 (en) Taxane compounds, compositions and methods
JPH11140071A (ja) バッカチン誘導体及びその製法
WO2013162922A1 (en) Taxane compounds, compositions and methods
EP1099696A2 (en) Preparation of oxazolidine
EP0747372A1 (en) Taxane derivatives from 14-beta-hydroxy-10 deacetybaccatin III